SOPHiA GENETICS SA Statistics
Share Statistics
SOPHiA GENETICS SA has 65.38M shares outstanding. The number of shares has increased by 0.11% in one year.
| Shares Outstanding | 65.38M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 51.15M |
| Failed to Deliver (FTD) Shares | 309 |
| FTD / Avg. Volume | 1.12% |
Short Selling Information
The latest short interest is 37.03K, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 37.03K |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 1.87 |
Valuation Ratios
The PE ratio is -3.86 and the forward PE ratio is -4.63.
| PE Ratio | -3.86 |
| Forward PE | -4.63 |
| PS Ratio | 4.89 |
| Forward PS | 2.4 |
| PB Ratio | 2.01 |
| P/FCF Ratio | -5.28 |
| PEG Ratio | n/a |
Enterprise Valuation
SOPHiA GENETICS SA has an Enterprise Value (EV) of 200.33M.
| EV / Earnings | -2.54 |
| EV / Sales | 3.21 |
| EV / EBITDA | -2.83 |
| EV / EBIT | -2.68 |
| EV / FCF | -3.47 |
Financial Position
The company has a current ratio of 4.16, with a Debt / Equity ratio of 0.12.
| Current Ratio | 4.16 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.12 |
| Total Debt / Capitalization | 10.94 |
| Cash Flow / Debt | -2.61 |
| Interest Coverage | -127.26 |
Financial Efficiency
Return on equity (ROE) is -0.52% and return on capital (ROIC) is -44.28%.
| Return on Equity (ROE) | -0.52% |
| Return on Assets (ROA) | -0.38% |
| Return on Capital (ROIC) | -44.28% |
| Revenue Per Employee | 145.05K |
| Profits Per Employee | -183.68K |
| Employee Count | 430 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 3 |
Taxes
| Income Tax | 486.00K |
| Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -26.04% in the last 52 weeks. The beta is 1.03, so SOPHiA GENETICS SA's price volatility has been higher than the market average.
| Beta | 1.03 |
| 52-Week Price Change | -26.04% |
| 50-Day Moving Average | 3.34 |
| 200-Day Moving Average | 4.08 |
| Relative Strength Index (RSI) | 54.6 |
| Average Volume (20 Days) | 27.66K |
Income Statement
In the last 12 months, SOPHiA GENETICS SA had revenue of 62.37M and earned -78.98M in profits. Earnings per share was -1.22.
| Revenue | 62.37M |
| Gross Profit | 42.91M |
| Operating Income | -74.83M |
| Net Income | -78.98M |
| EBITDA | -70.70M |
| EBIT | -74.83M |
| Earnings Per Share (EPS) | -1.22 |
Balance Sheet
The company has 123.25M in cash and 18.60M in debt, giving a net cash position of 104.65M.
| Cash & Cash Equivalents | 123.25M |
| Total Debt | 18.60M |
| Net Cash | 104.65M |
| Retained Earnings | -377.78M |
| Total Assets | 177.61M |
| Working Capital | 86.34M |
Cash Flow
In the last 12 months, operating cash flow was -48.58M and capital expenditures -9.23M, giving a free cash flow of -57.80M.
| Operating Cash Flow | -48.58M |
| Capital Expenditures | -9.23M |
| Free Cash Flow | -57.80M |
| FCF Per Share | -0.89 |
Margins
Gross margin is 68.8%, with operating and profit margins of -119.97% and -126.63%.
| Gross Margin | 68.8% |
| Operating Margin | -119.97% |
| Pretax Margin | -125.85% |
| Profit Margin | -126.63% |
| EBITDA Margin | -113.35% |
| EBIT Margin | -119.97% |
| FCF Margin | -92.67% |
Dividends & Yields
SOPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -36.09% |
| FCF Yield | -26.16% |
Analyst Forecast
The average price target for SOPH is $7, which is 107.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $7 |
| Price Target Difference | 107.1% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | -1.91 |
| Piotroski F-Score | 2 |